GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (STU:C26) » Definitions » 3-Year EPS without NRI Growth Rate

CellaVision AB (STU:C26) 3-Year EPS without NRI Growth Rate : 4.00% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CellaVision AB 3-Year EPS without NRI Growth Rate?

CellaVision AB's EPS without NRI for the three months ended in Dec. 2024 was €0.15.

During the past 12 months, CellaVision AB's average EPS without NRI Growth Rate was 8.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 4.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 8.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of CellaVision AB was 144.60% per year. The lowest was -38.50% per year. And the median was 13.30% per year.


Competitive Comparison of CellaVision AB's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, CellaVision AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where CellaVision AB's 3-Year EPS without NRI Growth Rate falls into.


;
;

CellaVision AB 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


CellaVision AB  (STU:C26) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


CellaVision AB 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of CellaVision AB's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

CellaVision AB Headlines

No Headlines